The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells

BACKGROUND: Despite the availability of hundreds of cancer drugs, there is insufficient data on the efficacy of these drugs on the extremely heterogeneous tumor cell populations of glioblastoma (GBM). RESULTS: The PKIS of 357 compounds was initially evaluated in 15 different GSC lines which then led...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Jianwen, Park, Soon Young, Nguyen, Nghi, Ezhilarasan, Ravesanker, Martinez-Ledesma, Emmanuel, Wu, Shaofang, Henry, Verlene, Piao, Yuji, Tiao, Ningyi, Brunell, David, Stephan, Clifford, Verhaak, Roel, Sulman, Erik, Balasubramaniyan, Veerakumar, de Groot, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828226/
https://www.ncbi.nlm.nih.gov/pubmed/29535822
http://dx.doi.org/10.18632/oncotarget.24041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828226/
https://www.ncbi.nlm.nih.gov/pubmed/29535822
http://dx.doi.org/10.18632/oncotarget.24041

Ejemplares similares